Sunday, 20 September 2026European Markets

X-FAB Stock Bullish Momentum With A 21% Jump In The Last 10 Sessions

Loading stream...

(vianews) - shares of x-fab (cac 40: xfab.pa) rose by a staggering 21.29% in 10 sessions from €8.08 to €9.80 at 17:07 est on thursday, after five sequential sessions in a row of gains. cac 40 is dropping 0.6% to €7,284.24, after three sequential sessions in a row of gains.

about x-fab

x-fab silicon foundries se operates as an analog/mixed-signal semiconductor technology foundry. the company manufactures silicon wafers for automotive, industrial, consumer, medical, and mobile communications, and other applications; and analog/mixed-signal integrated circuits, sensors, and micro-electro-mechanical systems. it also provides manufacturing and design support services for customers that design analog/mixed-signal integrated circuits and other semiconductor devices, as well as engineering and prototyping, outsourcing, technical, and design support services. the company serves integrated device manufacturers, original equipment manufacturers, and fabless semiconductor companies. it operates in belgium, germany, the united kingdom, austria, france, switzerland, denmark, sweden, finland, netherlands, ireland, singapore, china, japan, thailand, malaysia, korea, taiwan, hong kong, new zealand, the united states, and internationally. the company was founded in 1992 and is based in tessenderlo, belgium.

earnings per share

as for profitability, x-fab has a trailing twelve months eps of €0.56.

pe ratio

x-fab has a trailing twelve months price to earnings ratio of 17.5. meaning, the purchaser of the share is investing €17.5 for every euro of annual earnings.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, x-fab's stock is considered to be oversold (<=20).

more news about x-fab (xfab.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com